• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过质谱法对 HIV-1 传播/原始包膜糖蛋白的糖基化谱进行表征。

Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.

机构信息

Department of Chemistry, University of Kansas, Lawrence, Kansas, USA.

出版信息

J Virol. 2011 Aug;85(16):8270-84. doi: 10.1128/JVI.05053-11. Epub 2011 Jun 8.

DOI:10.1128/JVI.05053-11
PMID:21653661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3147976/
Abstract

The analysis of HIV-1 envelope carbohydrates is critical to understanding their roles in HIV-1 transmission as well as in binding of envelope to HIV-1 antibodies. However, direct analysis of protein glycosylation by glycopeptide-based mass mapping approaches involves structural simplification of proteins with the use of a protease followed by an isolation and/or enrichment step before mass analysis. The successful completion of glycosylation analysis is still a major analytical challenge due to the complexity of samples, wide dynamic range of glycopeptide concentrations, and glycosylation heterogeneity. Here, we use a novel experimental workflow that includes an up-front complete or partial enzymatic deglycosylation step before trypsin digestion to characterize the glycosylation patterns and maximize the glycosylation coverage of two recombinant HIV-1 transmitted/founder envelope oligomers derived from clade B and C viruses isolated from acute infection and expressed in 293T cells. Our results show that both transmitted/founder Envs had similar degrees of glycosylation site occupancy as well as similar glycan profiles. Compared to 293T-derived recombinant Envs from viruses isolated from chronic HIV-1, transmitted/founder Envs displayed marked differences in their glycosylation site occupancies and in their amounts of complex glycans. Our analysis reveals that the glycosylation patterns of transmitted/founder Envs from two different clades (B and C) are more similar to each other than they are to the glycosylation patterns of chronic HIV-1 Envs derived from their own clades.

摘要

分析 HIV-1 包膜糖蛋白对于了解其在 HIV-1 传播以及包膜与 HIV-1 抗体结合中的作用至关重要。然而,通过基于糖肽的质量映射方法直接分析蛋白质糖基化涉及使用蛋白酶对蛋白质进行结构简化,然后在进行质量分析之前进行分离和/或富集步骤。由于样品的复杂性、糖肽浓度的宽动态范围以及糖基化异质性,成功完成糖基化分析仍然是一个主要的分析挑战。在这里,我们使用了一种新的实验工作流程,该流程在胰蛋白酶消化之前包括全面或部分酶促去糖基化步骤,以表征两种源自急性感染的 B 型和 C 型 HIV-1 传播/原始包膜寡聚体的糖基化模式并最大程度地提高糖基化覆盖率,这两种包膜寡聚体在 293T 细胞中表达。我们的结果表明,两种传播/原始 Env 都具有相似的糖基化位点占有率以及相似的聚糖图谱。与从慢性 HIV-1 感染中分离的病毒在 293T 中表达的重组 Env 相比,传播/原始 Env 在糖基化位点占有率和复杂聚糖含量方面表现出明显差异。我们的分析表明,来自两个不同谱系(B 和 C)的传播/原始 Env 的糖基化模式彼此之间比其自身谱系的慢性 HIV-1 Env 的糖基化模式更为相似。

相似文献

1
Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.通过质谱法对 HIV-1 传播/原始包膜糖蛋白的糖基化谱进行表征。
J Virol. 2011 Aug;85(16):8270-84. doi: 10.1128/JVI.05053-11. Epub 2011 Jun 8.
2
Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins.鉴定早期传播/优势 HIV-1 gp120 包膜蛋白的宿主细胞系特异性糖基化特征。
J Proteome Res. 2013 Mar 1;12(3):1223-34. doi: 10.1021/pr300870t. Epub 2013 Feb 20.
3
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.膜锚定HIV-1包膜糖蛋白三聚体与可溶性gp140糖基化谱的比较分析
J Virol. 2015 Aug;89(16):8245-57. doi: 10.1128/JVI.00628-15. Epub 2015 May 27.
4
Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.通过特异性异质分布定义 HIV-1 包膜 N-聚糖微区。
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01177-18. Print 2019 Jan 1.
5
Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.对源自早期传播病毒的A组包膜免疫原引发的中和抗体反应的表征。
J Virol. 2008 Jun;82(12):5912-21. doi: 10.1128/JVI.00389-08. Epub 2008 Apr 9.
6
Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation.对293T细胞中瞬时和稳定表达的C组HIV-1 gp140三聚体进行糖基化和二硫键分析,确定了两种蛋白中均存在二硫键异质性以及O-连接糖基化的差异。
J Proteome Res. 2014 Sep 5;13(9):4012-27. doi: 10.1021/pr5003643. Epub 2014 Aug 6.
7
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.基于11种Env三聚体的HIV-1包膜糖蛋白生产的糖基化基准图谱。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02428-16. Print 2017 May 1.
8
Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.HIV-1包膜高变区V2、V4和V5的多样化以及传播/奠基者包膜糖基化的较高概率有利于异源中和广度的发展。
PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989. eCollection 2016 Nov.
9
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.针对具有传播奠基者Env的HIV-1细胞间传播的广谱中和抗体的效力降低及中和不完全
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02425-16. Print 2017 May 1.
10
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.B 型谱系传播/原始和慢性 HIV-1 包膜糖蛋白的表型和免疫比较。
J Virol. 2011 Sep;85(17):8514-27. doi: 10.1128/JVI.00736-11. Epub 2011 Jun 29.

引用本文的文献

1
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
2
Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1.超越聚糖障碍:非同源配体和蛋白质模拟方法引发针对 HIV-1 的广谱中和抗体。
J Biomed Sci. 2024 Aug 21;31(1):83. doi: 10.1186/s12929-024-01073-y.
3
Mannose-specific plant and microbial lectins as antiviral agents: A review.甘露糖特异性植物和微生物凝集素作为抗病毒药物:综述。
Glycoconj J. 2024 Feb;41(1):1-33. doi: 10.1007/s10719-023-10142-7. Epub 2024 Jan 20.
4
Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.糖基化对病毒免疫原的免疫原性和抗原性的影响。
Biotechnol Adv. 2024 Jan-Feb;70:108283. doi: 10.1016/j.biotechadv.2023.108283. Epub 2023 Nov 14.
5
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.CD4 结合位点免疫原在转基因和野生型动物中引发了针对 HIV-1 的异源中和抗体。
Sci Immunol. 2023 Feb 17;8(80):eade6364. doi: 10.1126/sciimmunol.ade6364. Epub 2023 Feb 10.
6
Glycan shield of the ebolavirus envelope glycoprotein GP.埃博拉病毒包膜糖蛋白 GP 的聚糖盾。
Commun Biol. 2022 Aug 4;5(1):785. doi: 10.1038/s42003-022-03767-1.
7
Dual Role of HIV-1 Envelope Signal Peptide in Immune Evasion.HIV-1 包膜信号肽的双重免疫逃逸作用。
Viruses. 2022 Apr 13;14(4):808. doi: 10.3390/v14040808.
8
Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS.采用 EThcD-sceHCD-MS/MS 对高度糖基化 HIV-1 gp120 的 N/O-糖基化进行顺序分析。
Front Immunol. 2021 Oct 21;12:755568. doi: 10.3389/fimmu.2021.755568. eCollection 2021.
9
The opportunity cost of automated glycopeptide analysis: case study profiling the SARS-CoV-2 S glycoprotein.自动化糖肽分析的机会成本:以 SARS-CoV-2 S 糖蛋白为例进行分析。
Anal Bioanal Chem. 2021 Dec;413(29):7215-7227. doi: 10.1007/s00216-021-03621-z. Epub 2021 Aug 27.
10
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.DC/L-SIGN对刺突糖蛋白的识别促进了SARS-CoV-2的转染,并且可以被一种糖模拟拮抗剂所抑制。
PLoS Pathog. 2021 May 20;17(5):e1009576. doi: 10.1371/journal.ppat.1009576. eCollection 2021 May.

本文引用的文献

1
Advances in LC platforms for drug discovery.用于药物发现的 LC 平台的进展。
Expert Opin Drug Discov. 2010 May;5(5):475-89. doi: 10.1517/17460441003733874. Epub 2010 Apr 5.
2
Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine Candidate.部分去糖基化蛋白质分析的方法开发及其在一种HIV包膜蛋白候选疫苗中的应用
Int J Mass Spectrom. 2011 Aug;305(2-3):209-216. doi: 10.1016/j.ijms.2010.11.009.
3
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.早期传播 HIV gp120 的基因型促进 α (4) β(7)-反应性,揭示 α (4) β(7) +/CD4+ T 细胞是黏膜传播的关键靶标。
PLoS Pathog. 2011 Feb;7(2):e1001301. doi: 10.1371/journal.ppat.1001301. Epub 2011 Feb 24.
4
Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.HIV-1包膜糖蛋白抗原性和免疫原性的表达系统依赖性调节。
J Mol Biol. 2010 Oct 15;403(1):131-147. doi: 10.1016/j.jmb.2010.08.033. Epub 2010 Aug 25.
5
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.免疫缺陷病毒的囊膜糖蛋白几乎完全是寡甘露糖抗原。
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13800-5. doi: 10.1073/pnas.1006498107. Epub 2010 Jul 19.
6
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.HIV-1 gp120 的糖基化模式取决于表达细胞的类型,并影响抗体的识别。
J Biol Chem. 2010 Jul 2;285(27):20860-9. doi: 10.1074/jbc.M109.085472. Epub 2010 May 3.
7
Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.使用 LC/MSMS 结合内切酶/外切糖苷酶混合物鉴定糖蛋白的 N-糖基化位点。
J Proteome Res. 2010 Jul 2;9(7):3598-607. doi: 10.1021/pr100129n.
8
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.复杂碳水化合物在人类免疫缺陷病毒 1 型感染和抗体中和抗性中的作用。
J Virol. 2010 Jun;84(11):5637-55. doi: 10.1128/JVI.00105-10. Epub 2010 Mar 24.
9
Genetic and antigenic features of the transmitted virus.病毒传播的遗传和抗原特征。
Curr Opin HIV AIDS. 2009 Sep;4(5):352-7. doi: 10.1097/COH.0b013e32832d9fef.
10
Sweetening the pot: adding glycosylation to the biomarker discovery equation.给研究“圣杯”加点甜:在生物标志物发现方程中加入糖基化修饰。
Clin Chem. 2010 Feb;56(2):223-36. doi: 10.1373/clinchem.2009.136333. Epub 2009 Dec 3.